Abstract Alzheimer's disease (AD), the most common form of dementia worldwide, is a mixed
proteinopathy (β-amyloid, tau and other proteins). Classically defined as a …

Alzheimer's disease (AD) is characterized by the presence of β-amyloid (Aβ) and tau, and
subcortical vascular cognitive impairment (SVCI) is characterized by cerebral small vessel …

Biomarkers play important roles in the diagnosis and differential diagnosis of Parkinson's
disease (PD). Thus, we carried out a systematic review and meta-analysis evaluating the …

Abstract Alzheimer's disease (AD), the most common form of dementia worldwide, is a mixed
proteinopathy (amyloid and tau). Originally defined as a clinicopathological entity, it is a …

Objectives Alzheimer's disease (AD) is characterised by amyloid-beta accumulation (A), tau
aggregation (T) and neurodegeneration (N). Vascular (V) burden has been found …

Background: We hypothesize that Alzheimer's disease (AD)-related pathology may
accelerate cognitive decline in patients with cardiovascular diseases. Objective: To …

Alzheimer's disease is defined by the presence of β-amyloid plaques and neurofibrillary tau
tangles potentially preceding clinical symptoms by many years. Previously only detectable …

Background: Cerebral small vessel disease (cSVD) and neurodegeneration are the two
main causes of dementia and are considered distinct pathological processes, while studies …

White Matter Hyperintensity Volume and Amyloid-PET Synergistically Impact Memory
Independent of Tau-PET in Older Adults Without Dementia - IOS Press You are viewing a …

Objectives Cognitive impairment caused by cerebrovascular disease accounts for more than
half of vascular dementia. However, neuropsychological tests are limited by their …